1260671-35-9 Usage
Uses
Used in Pharmaceutical Industry:
1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydrois utilized as a key intermediate in the synthesis of pharmaceuticals for its potential to contribute to the development of novel anticancer and antiviral agents. Its unique structure allows for the creation of bioactive compounds that can target specific biological pathways or viral processes, thereby offering new treatment options for various diseases.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydrois employed as a valuable building block for the design and synthesis of new drug candidates. Its heterocyclic nature and bromine substituent enable the exploration of various chemical modifications, leading to the discovery of compounds with improved pharmacological properties, such as enhanced potency, selectivity, and bioavailability.
Used in Organic Chemistry Research:
1H-Pyrrolo[3,2-b]pyridine, 5-bromo-2,3-dihydroalso serves as a synthetic intermediate in organic chemistry, where it can be used to construct more complex molecular architectures. Its reactivity and functional group compatibility make it a versatile component in the synthesis of a wide range of organic compounds, including natural products, agrochemicals, and other specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1260671-35-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,6,7 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1260671-35:
(9*1)+(8*2)+(7*6)+(6*0)+(5*6)+(4*7)+(3*1)+(2*3)+(1*5)=139
139 % 10 = 9
So 1260671-35-9 is a valid CAS Registry Number.
1260671-35-9Relevant academic research and scientific papers
NOVEL SUBSTITUTED TETRAHYDROQUINOLIN COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
-
, (2019/05/22)
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof (I). Also disclosed herein are uses of the compounds disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.
CANCER TREATMENTS TARGETING CANCER STEM CELLS
-
, (2019/11/19)
Disclosed are compounds, methods, compositions, and kits that allow for treating cancer by, e.g., targeting cancer stem cells. In some embodiments, the cancer is colorectal cancer, gastric cancer, gastrointestinal stromal tumor, ovarian cancer, lung cancer, breast cancer, pancreatic cancer, prostate cancer, testicular cancer, or lymphoma. In some embodiments, the cancer is liver cancer, endometrial cancer, leukemia, or multiple myeloma. The compounds utilized in the disclosure are of Formula (0), (O'), and (I):
